Trials / Completed
CompletedNCT00187278
Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization
Biventricular Pacing for Atrioventricular Block in Left Ventricular Dysfunction to Prevent Cardiac Desynchronization
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,833 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of the study is to evaluate if patients with a standard indication for permanent ventricular pacing, left ventricular ejection fraction without limit, or any QRS duration will profit from the prevention of ventricular desynchronisation.
Detailed description
The study will be performed as a controlled, single-blind, international, multicenter, prospective, randomized, parallel group design. In order to pragmatically examine the effectiveness of biventricular pacing in patients with an indication for ventricular pacing, the study group with biventricular pacing is compared to a control group with standard pacemakers which only allow univentricular (right ventricular) stimulation, as it has been the standard outside of clinical studies until so far.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Biventricular Pacing | Biventricular Pacemaker implant |
| DEVICE | RV Pacing | Standard Pacemaker implant |
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2014-05-01
- Completion
- 2014-10-01
- First posted
- 2005-09-16
- Last updated
- 2021-01-25
- Results posted
- 2021-01-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00187278. Inclusion in this directory is not an endorsement.